273 related articles for article (PubMed ID: 1354446)
1. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
Kundu SK; Merigan TC
AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446
[TBL] [Abstract][Full Text] [Related]
2. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
[TBL] [Abstract][Full Text] [Related]
3. Multiple CTL specificities against autologous HIV-1-infected BLCLs.
Ahearne PM; Morgan RA; Sebastian MW; Bolognesi DP; Weinhold KJ
Cell Immunol; 1995 Mar; 161(1):34-41. PubMed ID: 7867083
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques.
Venet A; Bourgault I; Aubertin AM; Kiény MP; Levy JP
J Immunol; 1992 May; 148(9):2899-908. PubMed ID: 1349322
[TBL] [Abstract][Full Text] [Related]
5. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
[TBL] [Abstract][Full Text] [Related]
6. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses.
Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A
J Immunol Methods; 2004 Aug; 291(1-2):153-63. PubMed ID: 15345313
[TBL] [Abstract][Full Text] [Related]
7. Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens.
Noguchi Y; Tateno M; Kondo N; Yoshiki T; Shida H; Nakayama E; Shiku H
J Immunol; 1989 Dec; 143(11):3737-42. PubMed ID: 2479689
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocyte activity in children infected with HIV.
Froebel KS; Aldhous MC; Mok JY; Hayley J; Arnott M; Peutherer JF
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S83-8. PubMed ID: 7865339
[TBL] [Abstract][Full Text] [Related]
9. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
[TBL] [Abstract][Full Text] [Related]
10. Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence.
McChesney M; Tanneau F; Regnault A; Sansonetti P; Montagnier L; Kieny MP; Rivière Y
Eur J Immunol; 1990 Jan; 20(1):215-20. PubMed ID: 2106442
[TBL] [Abstract][Full Text] [Related]
11. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
AIDS Vaccine Evaluation Group 022 Protocol Team
J Infect Dis; 2001 Feb; 183(4):563-70. PubMed ID: 11170981
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
13. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
Chenciner N; Michel F; Dadaglio G; Langlade-Demoyen P; Hoffenbach A; Leroux A; Garcia-Pons F; Rautmann G; Guy B; Guillon JM
Eur J Immunol; 1989 Sep; 19(9):1537-44. PubMed ID: 2676560
[TBL] [Abstract][Full Text] [Related]
14. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
[TBL] [Abstract][Full Text] [Related]
15. Virus-specific cytotoxic T-lymphocytes in HIV-2-infected cynomolgus macaques.
Voss G; Nick S; Otteken A; Lüke W; Stahl-Hennig C; Hunsmann G
AIDS; 1992 Oct; 6(10):1077-83. PubMed ID: 1466839
[TBL] [Abstract][Full Text] [Related]
16. Significance of the detection of HIV-1 gag- and/or pol-CD8/A2 T-lymphocytes in HIV-patients.
Wu R; Owen GC; Liu T; Shen GQ; Morris RI
Immunol Lett; 2005 Apr; 98(1):73-81. PubMed ID: 15790511
[TBL] [Abstract][Full Text] [Related]
17. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system.
Tanaka Y; Isobe A; Masuda M; Tozawa H; Koyanagi Y; Yamamoto N; Shida H
J Immunol; 1991 Nov; 147(10):3646-52. PubMed ID: 1940363
[TBL] [Abstract][Full Text] [Related]
19. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
Earl PL; Wyatt LS; Montefiori DC; Bilska M; Woodward R; Markham PD; Malley JD; Vogel TU; Allen TM; Watkins DI; Miller N; Moss B
Virology; 2002 Mar; 294(2):270-81. PubMed ID: 12009868
[TBL] [Abstract][Full Text] [Related]
20. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
Perales MA; Schwartz DH; Fabry JA; Lieberman J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):27-35. PubMed ID: 7648281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
